Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 May 2021Website:
http://www.tourmalinebio.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 7 min agoDividend
Analysts recommendations
Institutional Ownership
TRML Latest News
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced the promotion of Ryan Robinson, CPA, to Chief Financial Officer and Treasurer, effective June 25, 2024. Mr. Robinson most recently held the role of Vice President, Finance and Controller at Tourmaline, in addition to serving as Tourmaline's Interim Chief Financial Officer and Treasurer since October 2023.
Tourmaline Bio, Inc. (TRML) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Tourmaline Bio is advancing the use of its drug candidate TOUR006 for the treatment of thyroid eye disease and atherosclerotic cardiovascular disease. The ongoing phase 2b spiriTED study, which is using TOUR006 for the treatment of patients with active TED, is expected to release results in the first half of 2025. A phase 2 study, using TOUR006 for the treatment of patients with atherosclerotic cardiovascular disease, is expected to begin in 2024.
What type of business is Tourmaline Bio?
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
What sector is Tourmaline Bio in?
Tourmaline Bio is in the Healthcare sector
What industry is Tourmaline Bio in?
Tourmaline Bio is in the Biotechnology industry
What country is Tourmaline Bio from?
Tourmaline Bio is headquartered in United States
When did Tourmaline Bio go public?
Tourmaline Bio initial public offering (IPO) was on 07 May 2021
What is Tourmaline Bio website?
https://www.tourmalinebio.com
Is Tourmaline Bio in the S&P 500?
No, Tourmaline Bio is not included in the S&P 500 index
Is Tourmaline Bio in the NASDAQ 100?
No, Tourmaline Bio is not included in the NASDAQ 100 index
Is Tourmaline Bio in the Dow Jones?
No, Tourmaline Bio is not included in the Dow Jones index
When does Tourmaline Bio report earnings?
The next expected earnings date for Tourmaline Bio is 30 August 2024